Cargando…

Efficacy and safety of conventional long acting β2- agonists: systematic review and meta-analysis

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is usually considered one of the leading causes of death worldwide, so finding proper therapeutic strategies for this disease is of high importance. In this meta-analysis, we reviewed the existing literature on the efficacy and safety of conve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karbasi-Afshar, Reza, Aslani, Jafar, Ghanei, Mostafa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Babol University of Medical Sciences 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913706/ https://www.ncbi.nlm.nih.gov/pubmed/27386055

Ejemplares similares

Efficacy and safety of inhaler steroids in COPD patients: Systematic review and meta-analysis of randomized placebo-controlled trials
por: Karbasi-Afshar, Reza, et al.
Publicado: (2014)

GERD related micro-aspiration in chronic mustard-induced pulmonary disorder
por: Aliannejad, Rasoul, et al.
Publicado: (2012)

Long-acting β(2)-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety
por: Rossi, Andrea, et al.
Publicado: (2008)

Long-acting muscarinic antagonists vs. long-acting β (2) agonists in COPD exacerbations: a systematic review and meta-analysis
por: Maia, Israel Silva, et al.
Publicado: (2017)

Plasma proteomic profile of sulfur mustard exposed lung diseases patients using 2-dimensional gel electrophoresis
por: Mehrani, Hossein, et al.
Publicado: (2011)

Systematic review and network meta-analysis of the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler in comparison with other long-acting muscarinic antagonist/long-acting β(2)-agonist fixed-dose combinations in COPD
por: Siddiqui, Mohd Kashif, et al.
Publicado: (2019)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

How Well Establishment of Research Plans Can Improve Scientific Ranking of Medical Universities
por: Saadat, Seyed Hassan, et al.
Publicado: (2015)

The safety of long-acting β(2)-agonists in the treatment of stable chronic obstructive pulmonary disease
por: Decramer, Marc L, et al.
Publicado: (2013)

Comparative efficacy of long-acting β2-agonists as monotherapy for chronic obstructive pulmonary disease: a network meta-analysis
por: Donohue, James F, et al.
Publicado: (2017)

Efficacy and safety of the long-acting β(2)-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease
por: Ichinose, Masakazu, et al.
Publicado: (2015)

A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β(2)-Agonist (LABA) Combinations in COPD
por: Sion, Katya Y. J., et al.
Publicado: (2017)

Assessment of the safety of long-acting β(2)-agonists in routine asthma care: the ASTRO-LAB protocol
por: Van Ganse, Eric, et al.
Publicado: (2015)

Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies
por: Hernández, Gimena, et al.
Publicado: (2014)

Safety and Efficacy of Long-Acting Injectable Agents for HIV-1: Systematic Review and Meta-Analysis
por: Wang, Wenjing, et al.
Publicado: (2023)

The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
por: Tanimura, Kazuya, et al.
Publicado: (2023)

Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol
por: Beier, Jutta, et al.
Publicado: (2011)

Ultra Long-Acting β-Agonists in Chronic Obstructive Pulmonary Disease
por: Burkes, Robert M, et al.
Publicado: (2020)

ODP259 Evaluating the Efficacy and Safety of Long-Acting GLP-1 Receptor Agonist in T1DM Patients
por: Mohandas, Deene, et al.
Publicado: (2022)

The Efficacy and Safety of Topiramate for Prophylaxis of Migraine in Children
por: FALLAH, Razieh, et al.
Publicado: (2013)

Efficacy and safety of the CRTh2 antagonist AZD1981 as add-on therapy to inhaled corticosteroids and long-acting β(2)-agonists in patients with atopic asthma
por: Bateman, Eric D, et al.
Publicado: (2018)

Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat(®) device for maintenance treatment of COPD: comparison with the long-acting β(2)-agonist formoterol
por: Koch, Andrea, et al.
Publicado: (2017)

Optimal Bronchodilation for COPD Patients: Are All Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonists the Same?
por: Miravitlles, Marc, et al.
Publicado: (2018)

A Triage Model for Chemical Warfare Casualties
por: Khoshnevis, Mohammad Ali, et al.
Publicado: (2015)

The long-acting β(2)-adrenoceptor agonist olodaterol attenuates pulmonary inflammation
por: Wex, Eva, et al.
Publicado: (2015)

Efficacy and Safety of Aluminum Chloride in Controlling External Hemorrhage: An Animal Model Study
por: Nouri, Saeed, et al.
Publicado: (2015)

Treatment of Hepatitis C Virus Infection and Associated Vascular Complications: A Literature Review
por: Karbasi-Afshar, Reza
Publicado: (2014)

Combination therapy for airflow limitation in COPD
por: Ghanei, Mostafa, et al.
Publicado: (2012)

Comparison of the effectiveness and safety of formoterol versus salmeterol in the treatment of patients with asthma: A systematic review and meta-analysis
por: Velayati, Ashraf, et al.
Publicado: (2015)

Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids
por: Liao, Pei-An, et al.
Publicado: (2023)

A Novel Long-Acting Glucagon-Like Peptide-1 Agonist with Improved Efficacy in Insulin Secretion and β-Cell Growth
por: Kim, Hee Young, et al.
Publicado: (2014)

Prevalence of needlestick and sharps injuries in the healthcare workers of Iranian hospitals: an updated meta-analysis
por: Ghanei Gheshlagh, Reza, et al.
Publicado: (2018)

Inhaled Long-Acting β2-Agonists Do Not Increase Fatal Cardiovascular Adverse Events in COPD: A Meta-Analysis
por: Xia, Ning, et al.
Publicado: (2015)

Efficacy and Safety of Ghrelin Agonists in Patients with Diabetic Gastroparesis: A Systematic Review and Meta-Analysis
por: Hong, Seung Wook, et al.
Publicado: (2020)

The association between reflux esophagitis and airway hyper-reactivity in patients with gastro-esophageal reflux
por: Karbasi, Ashraf, et al.
Publicado: (2013)

Some Considerations About Cardiac Toxicity of Combination Therapy for Chronic Hepatitis C
por: Karbasi-Afshar, Reza, et al.
Publicado: (2013)

The role of combination therapy with corticosteroids and long-acting β(2)-agonists in the prevention of exacerbations in COPD
por: Cazzola, Mario, et al.
Publicado: (2006)

Long acting β(2)-adrenocepter agonists are not associated with atrial arrhythmias after pulmonary resection
por: Yamanashi, Keiji, et al.
Publicado: (2017)

Long-acting risperidone injection: efficacy, safety, and cost-effectiveness of the first long-acting atypical antipsychotic
por: Chue, Pierre
Publicado: (2007)

Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A review of their efficacy and tolerability
por: Garber, Alan J.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8cudhjs47shuithfd69tlsmsrf